Fibrinolytische Behandlung peripherer Arterien- und Venenverschlüsse / Michael Martin; B. J. Othmar Fiebach
| Medienart: |
Buch |
|---|
| Erscheinungsjahr: |
1994 |
|---|---|
| Erschienen: |
Bern Göttingen u.a.: Huber ; 1994 |
| Ausgabe: |
3., erg. und überarb. Aufl. von "Die Streptokinase-Behandlung peripherer Arterien- und Venenverschlüsse unter besonderer Berücksichtigung der ultrahohen Dosierung" |
| Sprache: |
Deutsch |
|---|
| Beteiligte Personen: |
Martin, Michael, 1932- [VerfasserIn] |
|---|
| ISBN: |
|---|
| Nlm: |
WG 510 |
|---|---|
| BKL: | |
| Themen: |
Angiographie |
| RVK: |
|---|
| Anmerkungen: |
Literaturangaben |
|---|
| Umfang: |
266 S. ; zahlr. Ill., Tab. |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
124328997 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 124328997 | ||
| 003 | DE-627 | ||
| 005 | 20240416231652.0 | ||
| 007 | tu | ||
| 008 | 930527s1994 sz ||||| 00| ||ger c | ||
| 015 | |a 93,N22,0376 |2 dnb | ||
| 015 | |a 94,A12,0705 |2 dnb | ||
| 016 | 7 | |a 930660811 |2 DE-101 | |
| 020 | |a 3456824033 |9 3-456-82403-3 | ||
| 035 | |a (DE-627)124328997 | ||
| 035 | |a (DE-576)039207870 | ||
| 035 | |a (DE-599)GBV124328997 | ||
| 035 | |a (OCoLC)727734622 | ||
| 035 | |a (OCoLC)30913758 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 044 | |c XA-CH |c XA-DE |c XD-CA | ||
| 060 | 0 | |a WG 510 | |
| 084 | |a 33 |2 sdnb | ||
| 084 | |a YC 1315 |2 rvk |0 (DE-625)rvk/153187:12921 | ||
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.85 |2 bkl | ||
| 100 | 1 | |a Martin, Michael |d 1932- |e verfasserin |0 (DE-588)1047616483 |0 (DE-627)77868279X |0 (DE-576)40141955X |4 aut | |
| 245 | 1 | 0 | |a Fibrinolytische Behandlung peripherer Arterien- und Venenverschlüsse |c Michael Martin; B. J. Othmar Fiebach |
| 250 | |a 3., erg. und überarb. Aufl. von "Die Streptokinase-Behandlung peripherer Arterien- und Venenverschlüsse unter besonderer Berücksichtigung der ultrahohen Dosierung" | ||
| 264 | 1 | |a Bern |a Göttingen [u.a.] |b Huber |c 1994 | |
| 300 | |a 266 S. |b zahlr. Ill., Tab. | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |f PENI |x XA-DE-NI |2 pdager |5 DE-35 | |
| 583 | 1 | |a Archivierung prüfen |c 20240324 |f DE-4165 |z 2 |2 pdager | |
| 650 | 2 | |a Arterial Occlusive Diseases |x drug therapy | |
| 650 | 2 | |a Peripheral Vascular Diseases |x drug therapy | |
| 650 | 2 | |a Thrombolytic Therapy | |
| 689 | 0 | 0 | |D s |0 (DE-588)4019661-6 |0 (DE-627)104552492 |0 (DE-576)208930310 |a Gefäßverschluss |2 gnd |
| 689 | 0 | 1 | |D s |0 (DE-588)4134002-4 |0 (DE-627)105675997 |0 (DE-576)209648597 |a Streptokinase |2 gnd |
| 689 | 0 | |5 DE-101 | |
| 689 | 1 | 0 | |D s |0 (DE-588)4019661-6 |0 (DE-627)104552492 |0 (DE-576)208930310 |a Gefäßverschluss |2 gnd |
| 689 | 1 | 1 | |D s |0 (DE-588)4002030-7 |0 (DE-627)104107073 |0 (DE-576)20884547X |a Angiographie |2 gnd |
| 689 | 1 | |5 DE-101 | |
| 689 | 2 | 0 | |D s |0 (DE-588)4019661-6 |0 (DE-627)104552492 |0 (DE-576)208930310 |a Gefäßverschluss |2 gnd |
| 689 | 2 | 1 | |D s |0 (DE-588)4195252-2 |0 (DE-627)10521325X |0 (DE-576)21009981X |a Perkutane transluminale Angioplastie |2 gnd |
| 689 | 2 | |5 DE-101 | |
| 700 | 1 | |a Fiebach, Berthold J. Othmar |e verfasserin |0 (DE-627)1234639769 |0 (DE-576)164639764 |4 aut | |
| 780 | 0 | 0 | |i 2. Aufl. u.d.T. |a Die Kurzzeitlyse mit ultrahoher Streptokinase-Dosierung zur Behandlung peripherer Arterien- und Venenverschlüsse |
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_22_i06404 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a ISIL_DE-27 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a ISIL_DE-28 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a ISIL_DE-3 | ||
| 912 | |a GBV_ILN_65_a150 | ||
| 912 | |a GBV_ILN_72 | ||
| 912 | |a ISIL_DE-35 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a ISIL_DE-354 | ||
| 912 | |a GBV_ILN_92 | ||
| 912 | |a ISIL_DE-33 | ||
| 912 | |a GBV_ILN_348 | ||
| 912 | |a ISIL_DE-Nbg4 | ||
| 912 | |a GBV_ILN_678 | ||
| 912 | |a ISIL_DE-Ner1 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a ISIL_DE-15 | ||
| 935 | |i Blocktest | ||
| 936 | r | v | |a YC 1315 |b Therapie (medikamentöse, physikalische Rehabilitation) |k Medizin |k Innere Medizin |k Spezielle Innere Medizin |k Angiologie |k Peripherer Blutkreislauf |k A. Formalschlüssel |k Allgemeine Literatur zu einem Hauptgebiet |k Therapie (medikamentöse, physikalische Rehabilitation) |0 (DE-627)1271583402 |0 (DE-625)rvk/153187:12921 |0 (DE-576)201583402 |
| 936 | b | k | |a 44.38 |j Pharmakologie |0 (DE-627)106409743 |
| 936 | b | k | |a 44.85 |j Kardiologie |j Angiologie |0 (DE-627)106409417 |
| 951 | |a BO | ||
| 980 | |2 22 |1 01 |x 0018 |b 17872565X |c 00 |f 18/64 |d Med B/5457 |e u |j --%%-- |c 03 |f --%%-- |d Med 4: M-10-2-24 |e --%%-- |j --%%-- |c 04 |f --%%-- |d Med B 1994/356 |e --%%-- |j --%%-- |y zi06404 |z 25-03-96 | ||
| 980 | |2 31 |1 01 |x 0027 |b 149379595 |c 00 |f Mag3 |d Mag3 B 3097 |e u |j --%%-- |c 09 |f --%%-- |d 94 NB 263/1 |e --%%-- |j --%%-- |y n |z 13-02-01 | ||
| 980 | |2 31 |1 02 |x 0027 |b 149379609 |c 00 |f J 43 |d MED:UI:4640:Mar::1994 |e d |j --%%-- |c 09 |f --%%-- |d 94 NB 263/2 |e --%%-- |j --%%-- |y r |z 13-02-03 | ||
| 980 | |2 62 |1 01 |x 0028 |b 508445647 |c 00 |f 28/BB4 |d YC 1315 M382(3) |e u |j --%%-- |y zi062 |z 23-08-01 | ||
| 980 | |2 65 |1 01 |x 0003 |b 136744397 |c 00 |f Ha 150 |d 44.85/2001:0015 |e u |j --%%-- |y za150 |z 23-11-94 | ||
| 980 | |2 72 |1 01 |x 0035 |b 136473164 |c 00 |f ZEN |d 94/21401 |e u |j --%%-- |y kz |z 02-12-94 | ||
| 980 | |2 74 |1 01 |x 0354 |b 122443160 |c 00 |f Magazin |d MB 5235/3 |e u |j --%%-- |y r |z 26-06-14 | ||
| 980 | |2 92 |1 01 |x 0033 |b 919684432 |c 00 |f --%%-- |d 45 B 198 |e u |j --%%-- |y z |z 09-02-09 | ||
| 980 | |2 348 |1 01 |x 4348 |b 838491707 |c 00 |f MB |d 0502 10 |e u |j --%%-- |y zm |z 05-10-07 | ||
| 980 | |2 678 |1 01 |x 4678 |b 1445368838 |c 00 |f Bib |d 050210 |e c |j --%%-- |y nf |z 13-11-13 | ||
| 980 | |2 2010 |1 01 |x DE-15 |b 3242390776 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 27-05-94 | ||
| 982 | |2 31 |1 00 |x DE-27 |8 00 |a Gefässverschluss / Streptokinase | ||
| 982 | |2 31 |1 00 |x DE-27 |8 01 |a Gefässverschluss / Angiographie | ||
| 982 | |2 31 |1 00 |x DE-27 |8 02 |a Gefässverschluss / Perkutane transluminale Angioplastie | ||
| 982 | |2 65 |1 01 |x 0003 |8 00 |a Gefäßverschluss | ||
| 982 | |2 74 |1 00 |x DE-354 |8 00 |a Arterial Occlusive Diseases-drug therapy | ||
| 982 | |2 74 |1 00 |x DE-354 |8 01 |a Peripheral Vascular Diseases-drug therapy | ||
| 982 | |2 74 |1 00 |x DE-354 |8 02 |a Thrombolytic Therapy | ||
| 982 | |2 348 |1 00 |x DE-Nbg4 |8 00 |a Gefäßkrankheiten, Therapie | ||
| 982 | |2 348 |1 00 |x DE-Nbg4 |8 00 |a Arterienverschlüsse, Therapie | ||
| 982 | |2 348 |1 00 |x DE-Nbg4 |8 00 |a Venenverschlüsse, Therapie | ||
| 982 | |2 678 |1 00 |x DE-Ner1 |8 00 |a Arteriosklerose | ||
| 982 | |2 678 |1 00 |x DE-Ner1 |8 01 |a Therapie | ||
| 982 | |2 678 |1 00 |x DE-Ner1 |8 02 |a Kardiologie | ||
| 983 | |2 31 |1 00 |x DE-27 |8 00 |a MED:UI | ||
| 983 | |2 65 |1 01 |x 0003 |8 00 |a 44.85 | ||
| 983 | |2 348 |1 00 |x DE-Nbg4 |8 00 |a 0502 10 | ||
| 984 | |2 22 |1 01 |x 0018 |a 056036257 | ||
| 984 | |2 31 |1 01 |x 0027 |a 27$007557434 | ||
| 984 | |2 31 |1 02 |x 0027 |a 27$005492734 | ||
| 984 | |2 62 |1 01 |x 0028 |a 28$005308712 | ||
| 984 | |2 65 |1 01 |x 0003 |a 3/150$0000166X | ||
| 984 | |2 72 |1 01 |x 0035 |a 35$030366895 |x 00 | ||
| 984 | |2 74 |1 01 |x 0354 |a 354$10180192 | ||
| 984 | |2 92 |1 01 |x 0033 |a 33$002059959 | ||
| 985 | |2 22 |1 01 |x 0018 |a h64 monuma | ||
| 985 | |2 22 |1 01 |x 0018 |a 1996.12 | ||
| 985 | |2 31 |1 01 |x 0027 |a C94/R/19 | ||
| 985 | |2 31 |1 02 |x 0027 |a C94/R/1821 | ||
| 985 | |2 65 |1 01 |x 0003 |a 150/2001/00033 | ||
| 985 | |2 72 |1 01 |x 0035 |a P 1994.225 | ||
| 985 | |2 74 |1 01 |x 0354 |a MB 5235/3 | ||
| 985 | |2 348 |1 01 |x 4348 |a 115/1994 | ||
| 985 | |2 678 |1 01 |x 4678 |a 97:228 | ||